ABSTRACT. Patients with cystic fibrosis (CF) have im-
HSA, human serum albumin paired natural (preinfection) IgG2 antibody responses to PBS, phosphate-buffered saline Pseudomonas aeruginosa lipopolysaccharide. To investi-NGS, normal goat serum gate the basis for this defect, we measured natural IgG and OPD, o-phenylenediamine IgGI-4 antibody levels to Huemophilus influenzae type b EU, ELISA units polyribophosphate (PRP) and tetanus toxoid by enzymeMab, monoclonal antibody linked immunosorbent assay in 24 adult C F patients and 20 normal controls. Immunoglobulin heavy-and light-chain allotvaes were determined on 146 Caucasian C F oatients " -and 96 controls. The tetanus toxoid-specific IgG response was predominantly IgCl. C F and control subjects had similar IgG and IgGl antibody levels. The PRP-specific IgG response was predominantly IgG2. In contrast to tetanus toxoid results, C F patients had lower geometric mean level of PRP-specific IgG compared to normal controls ( p = 0.0036). ELISA results were confirmed by liquid-phase %-PRP-binding assay: C F patients had a geometric mean serum antibody level of 395 versus 922 ng/ ml in controls ( p = 0.0044). PRP-specific IgG2 levels were also depressed in C F patients ( p = 0.03). C F patients had a lower prevalence of the A2m(2) allotype than the local racially matched control sample ( p < 0.025). Other allotype prevalences including G2m(n) and Km(1) were similar. Impaired IgGZ antibody responses to microbial polysaccharide surface antigens in C F patients might predispose them to persistent endobronchial infection and lead to production of nonopsonizing isotype responses. The potential role of A2m (2) 
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Chronic airways infection with PA occurs in more than 80% of patients with CF and is responsible for most morbidity and mortality seen in this disease. The unique anatomic and bacteriologic features of this infection strongly suggest a local immune deficiency. The most promising candidate for such an immune deficiency is PA-specific nonopsonizing or blocking antibody detected in PA-infected CF patients (1, 2), since opsonic IgG antibodies specific for PA surface antigens such as LPS are essential for normal pulmonary and systemic phagocytic clearance (3, 4) .
Several mechanisms might underlie the production of blocking antibodies to PA by CF patients. Proteolytic degradation of IgG into dysfunctional fragments has been demonstrated in vivo in CF bronchial lavage fluids and i n vitro upon incubation with PA-derived elastase ( 5 , 6) . Changes in Fc-mediated effector function secondary to altered glycosylation of CF immunoglobulin could conceivably play a role (7) . However, neither of these explanations account for the antigenic restriction of the opsonic defect to PA. In contrast, a change in the pattern (isotype distribution) of the antibody response subsequent to initial colonization might result in production of blocking antibody, an alteration capable of causing an antigen-specific immune deficiency (8) (9) (10) .
In studying this phenomenon, we were struck by the unexpected finding that patients with CF who were not infected with PA appeared to have an impaired humoral immune response to PA LPS, as manifested by subnormal levels of PA LPS-specific IgG2 antibodies and an apparent redistribution of the response to nonopsonizing IgG4 (8) .
The adult human antibody response to polysaccharide antigens is normally at least partly restricted to the IgG2 subclass ( I I-16). It seems possible that an inability to respond with an adequate IgG2 response could predispose to infection with polysaccharide-encapsulated pathogens such as PA. Herein, we explored the hypothesis that CF patients have a deficient response to polysaccharide antigens by measuring natural IgG and IgG l -4 subclass antibody levels to PRP, and a control protein antigen, TT, in older patients with CF compared to normal subjects. We also examined allotypic markers on CF immunoglobulin to assess possible genetic contributions to impaired responses. 7 10 MOSS Statistical analysis. Geometric mean antibody levels were compared by the Mann-Whitney U test after logarithmic transformation, using two-tailed p values for significance. Results were also analyzed using two-tailed Student's t test on log transformed antibody values, but the nonparametric test results are reported due to non-Gaussian distribution histograms of some of the data. Parametric and nonparametric significance values wcrc in close agreement and in no case were discordant conclusions reached by the two methods. Allotype prevalences were compared by the x2 statistic with Yates' correction of continuity.
Statistical calculations were performed using Statview 5 12 statistical software package (Brainpower, Inc., Calabasas, CA).
RESULTS
Patients with C F had similar T T IgG antibody levels to controls (Fig. IA) . The geometric mean value for the C F group was 8075 versus 6883 EU in the control group ( p > 0.2). Sixteen C F patients who were chronically infected with PA had similar T T antibody levels to eight C F patients without PA infection (geometric mean = 8390 verszrs 6353 EU, p = 0.13).
The IgG subclass antibody response to T T in healthy adults was predominantly IgG 1, with minor contributions from IgG2-4. The hyperimmune standard globulin preparation used to standardize the ELISA contained the following distribution of IgG subclass TT antibodies, as determined in three separate experiments: 52-58% IgG1, 15-1 7% IgG2, 12-14% IgG3, and 15-17% IgG4. C F patients demonstrated a similar distribution of humoral response to TT, with IgGl predominance. T T IgG and IgG1 antibody levels showed a high degree of correlation for all subjects (r = +0.87, p < 0.001).
Individual serum IgGl antibody levels to TT are shown in Figure 1B . The geometric mean T T IgGl antibody levels were similar in the patients with C F compared to normal controls (327 verszis 398 EU, respectively). C F patients infected with PA and C F patients without PA infection had similar levels of T T IgG 1 (402 versus 2 18 EU, p = 0.14).
The PRP-specific IgG antibody levels determined by ELISA are shown in Figure 2A . Unlike the results seen with TT, C F patients as a group had significantly lower serum IgG antibody levels to PRP compared to normal subjects. This occurred despite the fact that one control subject had a P R P IgG level below the detection limit o f the standard curve (30 ng/ml). Thc gcornctric mean IgG P R P antibody level in patients with C F was 1140 verszis 23 10 EU in controls ( p = 0.0036). C F patients infected with PA and C F patients without PA infection had similar P R P IgG antibody levels (geometric mean = 1 1 10 verszis 1200).
To further examine the response to PRP, a radioantigenbinding assay detecting antibodies of all isotypes binding to 'H-PRP and precipitablc by 12.5% polyethylene glycol was used (2 1). In this assay, C F patients also demonstrated a significantly lower response (Table 1 ). The geometric mean antibody level in C F patient group was 395 versus 922 ng/ml in the control group ( p = 0.0044). The results of the 3H-PRP radioantigen-binding assay and the PRP IgG ELISA correlated well ( r = +0.65, p < 0.001). The control subject who had the lowest level of PRPspecific IgG by ELISA (see above) had 88 ng/ml 3H-PRP binding antibody in the radioantigen assay. Six patients with C F (25%) and two controls (10%) had 'H-PRP binding levels <I50 ng/ml.
The normal adult IgG antibody response to PRP was predominantly IgG2, although a variable minority contribution from IgG 1 was apparent in some individuals in IgG 1-4 subclass ELISA using equivalent signal-generating dilutions of subclass-specific secondary monoclonal antibodies (Fig. 3) . The distribution of IgG subclasses in the reference serum was determined in three experiments to be approximately 28-3 1 % IgG 1, 5 1-52% IgG2. 10-13% IgG3, and 7-8% IgG4. The distribution of C F patient IgG subclass antibody response to PRP appeared similar to healthy controls. In particular, there was no clear-cut evidence of compensatory shifts in IgG subclass antibody response toward 
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IgG1 (24-27). Our data confirm these studies and indicate that patients with C F also respond to T T with a dominant IgGl response, which is quantitatively similar to that of controls. A variable minority contribution of IgG2-4 T T antibodies may be seen in individual subjects, with IgG4 being particularly important in some (25-27). Examination of the antibody response to polysaccharide antigens highlights a number of qualitative and quantitative differences vis-a-vis the response to proteins. First, the isotype pattern of response is qualitatively distinct, with predominance of IgG2 antibodies (1 1-16) . Second, the ontogeny of response differs, with a later maturation of immune responsiveness, which for some antigens may extend well into the latter years of childhood (28, 29). T o eliminate the ontogenetic factor, we restricted our investigation in this study to immunologically adult (>I6 yr old) subjects.
Antibodies to H. influenzae type b capsular P R P are present in virtually all unimmunized adults at levels sufficient to prevent invasive Ii. influenzae type b disease (r 150 ng/ml precipitable antibody) (19). In contrast to immunization-induced T T antibodies, PRP antibodies are thought to be induced as a result of natural exposure to enteric microbial flora, especially Escherichia coli, which has a capsular polysaccharide antigen (K 100) which is cross-reactive with PRP (30).
The major finding of this study is that adult C F patients have significantly lower levels of serum PRP IgG antibodies than controls (Fig. 2) . The normal human IgG antibody response to PRP is partly restricted to IgG2, with a variable minority contribution from IgGl (12, 31). Recently, Weinberg et a/. (32) demonstrated that IgG2 subclass PRP antibodies were functional in in vitro bactericidal and in vivo rat bacteremia protection assays. Similar data supporting a protective biologic role for polyclonal or monoclonal human IgG2 antibodies to other polysaccharides, such as type 111 group B Stre/j/ococcus capsule and P.scudomonus aeruginosu LPS, have been obtained (Masuho Y, personal communication) (33). Moreover, a number of recent clinical studies suggest that deficiency of IgG2 (or pathogen-specific IgG2 antibodies even when IgG2 levels are normal) may predispose to sinopulmonary infection (34. 35). C F patients in our study, as with the normal controls, made a predominantly IgG2 response, without evidence of a compensatory shift to IgG1 or other IgG isotypes. As with IgG antibodies, PRP-specific IgG2 levels were generally lower in C F patients. These findings, particularly in light of our previous observations regarding P. ueruginosa LPS antibodies (8) , suggest IgG2 responses to polysaccharide antigens, of potential functional importance, might be impaired in C F patients.
The human response to P R P includes IgM and IgA antibodies, which we did not directly measure. However, we confirmed the lower PRP IgG antibody levels in C F patients determined by ELISA by radioantigen-binding assay (2 I), suggesting that compensatory or increased systemic IgA or IgM antibody responses d o not occur to a major degree in these patients.
An alternative explanation for lower PRP antibody levels in C F patients is that antigenic exposure might somehow be less than that experienced by normal individuals. In particular, since natural PRP antibodies are thought to arise from responses to normal gut flora (especially E. coli) (30) could frequent antibiotic treatment deprive the C F individual of this antigenic stimulation? Available data on colonization rates and immune responses to enteric bacteria, including E. coli, in patients with C F would appear to preclude this possibility, since these are both normal or increased in C F patients despite vigorous antibiotic treatment (36-39). Increased direct PRP antigenic stimulation in C F patients seems unlikely, however, given the fact that most il. influenzae respiratory tract colonization and infection in C F patients is due to nontypeable, acapsulate strains (40).
To investigate a possible genetic basis for this impairment, we examined allotypes of C F and control immunoglobulins. We found that the allotypic light chain marker Km(l), previously associated in certain populations with enhanced immune responsiveness to P R P and other polysaccharide antigens (4 1 -45), had a lower prevalence in our C F sample population than controls. Another allotype, found on IgA2 heavy chains, A2m(2) (46), was also less frequent in C F patients. A2m(2) is relatively rare in Caucasian populations and more common in blacks and Orientals (47). We excluded the latter racial groups from our analysis, and the presence or absence of Hispanic individuals did not alter the results. T o our knowledge, no studies of IgA allotypes and immune responses have been published. It is intriguing to note, however, that IgA2 plays a prominent role in local mucosal IgA production (48). In particular, IgA2 antibodies appear to provide the major portion of the mucosal IgA antibody response to bacterial LPS and staphylococcal ribitol teichoic acid (15, 49). Aberrations in the secretory IgA system have been reported in C F patients, but no data on IgA subclass composition were presented (50). Pathology in IgA, IgG, or both isotypes could play a role in development of C F lung disease. Independent, complementary functions for secretory IgA and IgG subclass antibodies in pulmonary defense are currently postulated via prevention of mucosal microbial adherence and colonization by the former, and subsequent opsonophagocytosis if necessary by the latter ( 5 1).
In future studies it will be necessary to examine primary and anamnestic responses of C F patients to polysaccharide vaccines. It will also be useful to study fluctuations in bacterial polysaccharide-specific antibody levels over time in relation to respiratory tract colonization and episodes of infection. At present, the role of a rather restricted but potentially important immune response, impaired IgG2 antibody responses to polysaccharide antigens, in predisposing C F patients to chronic airway infection remains speculative. Continued study of host responses seems likely to provide additional clues to those lines of inquiry focused solely on bacterial virulence factors in understanding the uniquely circumscribed nature of pulmonary infection in CF.
